Cardiac Rehabilitation Participation and South Asian Service Users

NCT06239558 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-03-13

No results posted yet for this study

Summary

The goal of this qualitative study is to learn about the barriers and enablers to cardiac rehabilitation, experience by South Asian service users based in the UK who have experienced an acute cardiac event and been referred for CR. This may allow NHS programmes to make adaptations to their services to enhance uptake, adherence and completion for this ethnic population. The main questions it aims to answer are:

* What are the barriers and enablers to uptake, adherence or completion of CR experienced by service users with South Asian heritage?
* What adaptations to the CR service could be implemented to overcome identified barriers, enhance enablers and result in increased uptake, adherence or completion to CR?

Participants will be invited to participate in a semi-structured interview and/or a focus group to explore lived experiences that can answer the research questions.

Conditions

  • Cardiac Rehabilitation
  • South Asian Service Users

Interventions

OTHER

Qualitative exploration

Semi-structured Interviews and focus group

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER
  • University Hospitals, Leicester

    collaborator OTHER
  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV
  • University of Leicester

    lead OTHER

Principal Investigators

  • Sally J Singh, PhD · University of Leicester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-29
Primary Completion
2024-09-30
Completion
2024-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06239558 on ClinicalTrials.gov